Vector-borne pathogens don’t survive by chance, they survive by design. Through immune suppression, antigenic variation, and tissue sequestration, these organisms persist in the host while evading immune clearance and complicating diagnosis.
Vector-borne pathogens don’t survive by chance, they survive by design. Through immune suppression, antigenic variation, and tissue sequestration, these organisms persist in the host while evading immune clearance and complicating diagnosis.
When symptoms persist, shift, or contradict standard test results, clinicians need a clearer diagnostic path.
This webinar provides an evidence-informed framework for evaluating elusive vector-borne pathogens that often go undetected in chronic or multisystem presentations.
Vector-borne pathogens don’t survive by chance, they survive by design. Through immune suppression, antigenic variation, and tissue sequestration, these organisms persist in the host while evading immune clearance and complicating diagnosis.
Borrelia Diagnostics Update (2022) Galaxy Diagnostics cofounder/CEO, Dr. Amanda Elam, and Director of Research and Development/Asst. Lab Director, Dr. Jennifer Miller discuss the latest updates to Borrelia testing and recommendations in this webinar.
Montacalvo Platform for Tick-Borne Illness Education Learn More
Understanding Bartonella: A One Health Perspective (2015)
Approximately 75% of emerging infectious diseases affecting humans are zoonotic (transmitted from animals to humans). Vectors (e.g., fleas, ticks, lice, biting flies, etc.) play an important role in transmitting zoonotic infections. Individuals at high-risk of acquiring Bartonella infection include those who work or live with animals, or those with high exposure to fleas, ticks, lice and biting flies. Stealth infections such as bartonellosis are increasingly implicated in complex chronic disease syndromes, yet are extremely difficult to diagnose accurately.
